KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Hologic (HOLX) Cash & Equivalents (2016 - 2025)

Hologic (HOLX) has disclosed Cash & Equivalents for 17 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 21.65% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 21.65% year-over-year, with the annual reading at $2.0 billion for FY2025, 9.29% down from the prior year.
  • Cash & Equivalents hit $2.2 billion in Q4 2025 for Hologic, up from $2.0 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.7 billion in Q3 2023 to a low of $816.4 million in Q1 2021.
  • Historically, Cash & Equivalents has averaged $1.9 billion across 5 years, with a median of $2.2 billion in 2024.
  • Biggest five-year swings in Cash & Equivalents: soared 187.01% in 2022 and later plummeted 34.42% in 2025.
  • Year by year, Cash & Equivalents stood at $1.4 billion in 2021, then surged by 71.83% to $2.4 billion in 2022, then decreased by 20.86% to $1.9 billion in 2023, then decreased by 7.76% to $1.8 billion in 2024, then rose by 21.65% to $2.2 billion in 2025.
  • Business Quant data shows Cash & Equivalents for HOLX at $2.2 billion in Q4 2025, $2.0 billion in Q3 2025, and $1.7 billion in Q2 2025.